glp 1 and type 2 diabetes GLP-1 receptor agonists in the treatment of – state-of-the-art Who is suitable for GLP-1?

5-7 Multiple studies have linked gut dysbiosis a change or imbalance in the diversity, composition and functions of the microbiota to reduced GLP-1 levels

FM 2.0 principle : Quantify vitality, not just volume

Current clinical evidence suggests that starting GLP-1 therapy in gastroparesis requires careful medical evaluation and baseline gastric function assessment, not automatic exclusion from treatment

Maternal & Child Nutrition

Tirzepatide may initiate appetite changes slightly faster for some patients due to its dual GIP-receptor activity, which adds an additional satiety pathway beyond standard GLP-1 signaling